NCT01582191
- Conditions
- Advanced Malignant Neoplasm, Disease Attributes, Metastatic Malignant Neoplasm, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Refractory Malignant Neoplasm
Explore clinical trials studying Refractory Malignant Neoplasm. Study availability and eligibility vary by location and protocol.
11 public trials
0 recruiting studies
Refractory Malignant Neoplasm trial results
Completed
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
NCT03108131
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendix Adenocarcinoma, +20 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
NCT02143401
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +34 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT02595866
- Conditions
- AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Zuckerberg San Francisco General Hospital San Francisco, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- Yale University New Haven, Connecticut, United States
NCT04059393
- Conditions
- Care Giver, Disease Attributes, Neoplasms, +5 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT04409314
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT01624766
- Conditions
- Advanced Malignant Neoplasm, Disease Attributes, Metastatic Malignant Neoplasm, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01531361
- Conditions
- Advanced Malignant Neoplasm, BRAF Gene Mutation, Disease Attributes, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
NCT02286687
- Conditions
- ATM Gene Mutation, Advanced Malignant Neoplasm, BRCA1 Gene Mutation, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Financial Distress in Advanced Cancer Patients
NCT04053517
- Conditions
- Advanced Malignant Neoplasm, Disease Attributes, Locally Advanced Malignant Neoplasm, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States